1. Liu, Wenli, Chen, Yutong, Yang, Jinqiang, Guo, Mingliang, Wang, Li. 2023. B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition in hepatocellular carcinoma based on pan-cancer analysis. In The journal of gene medicine, 25, e3552. doi:10.1002/jgm.3552. https://pubmed.ncbi.nlm.nih.gov/37337736/
2. Jiang, Tian, Wu, Hao, Lin, Miao, Ruan, Yuanyuan, Feng, Mingxiang. . B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway. In Carcinogenesis, 42, 621-630. doi:10.1093/carcin/bgaa141. https://pubmed.ncbi.nlm.nih.gov/33367717/
3. Inamori, Kei-Ichiro, Nakamura, Katsuya, Shishido, Fumi, Sekijima, Yoshiki, Inokuchi, Jin-Ichi. 2024. Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population. In Frontiers in neuroscience, 18, 1437668. doi:10.3389/fnins.2024.1437668. https://pubmed.ncbi.nlm.nih.gov/39145292/
4. Wang, Zhifeng, Liu, Jiaxin, Wang, Xiaoming, Wang, Yilin, Wu, Weicheng. 2024. Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis. In Molecular biomedicine, 5, 65. doi:10.1186/s43556-024-00231-w. https://pubmed.ncbi.nlm.nih.gov/39616302/
5. Furukawa, Koichi, Ohmi, Yuhsuke, Ji, Shuting, Hashimoto, Noboru, Furukawa, Keiko. 2017. Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis. In Biochimica et biophysica acta. General subjects, 1861, 2479-2484. doi:10.1016/j.bbagen.2017.06.007. https://pubmed.ncbi.nlm.nih.gov/28602513/